Mycobacterium bovis infection of an axillary-femoral bypass graft after intravesical bacille Calmette-Guérin immunotherapy for bladder cancer.
We report a case of bacillus Calmette-Guérin (BCG) infection of an axillary-femoral bypass graft presenting approximately 10 months after the initiation of intravesicular bacillus Calmette-Guérin for the treatment of bladder cancer. The patient's clinical course included removal of the bypass graft and antimycobacterial treatment with isoniazid, rifampin, and ethambutol for 9 months.
Shakir
Faiz
F
Department of Medicine, Infectious Diseases Section, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA.
Dang
Van
V
Bronze
Michael S
MS
Liu
Cheng
C
Machado
Linda
L
D000283:Administration, Intravesical; D001157:Arterial Occlusive Diseases / Q000601:surgery; D001366:Axillary Artery / Q000601:surgery*; D001500:BCG Vaccine / Q000009:adverse effects*; D005263:Femoral Artery / Q000601:surgery*; D006801:Humans; D007083:Iliac Artery; D008297:Male; D008875:Middle Aged; D014381:Tuberculosis, Cardiovascular / Q000209:etiology*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine